Beijing Ji Shui Tan Hospital

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Childhood cancers1 trial
• Obesity1 trial
• Osteoarthritis1 trial
• Osteoporosis1 trial

Phase

• Phase 32 trials

Status

• Recruiting2 trials
• Not yet recruiting1 trial

Lead sponsor

• Beijing Jishuitan Hospital1 trial
• Eli Lilly and Company1 trial
• Shanghai JMT-Bio Inc.1 trial

Running trials

• Recruiting

  Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight

  NCT07353931· Phase 3· Eli Lilly and Company· Source

  Contact: Xiaoli Deng (principal investigator)

• Not yet recruiting

  A Study to Evaluate the Efficacy and Safety of Narlumosbart (JMT103) in Patients With Giant Cell Tumor of Bone

  NCT05813665· Phase 3· Shanghai JMT-Bio Inc.· Source

  Contact: Xiaohui Niu, B.M.

• Recruiting

  Chinese Second Hip Fracture Evaluation

  NCT03461237· Beijing Jishuitan Hospital· Source

  Contact: Xiaoguang Cheng, MD

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Childhood cancers1 recruiting
• Obesity1 recruiting
• Osteoarthritis1 recruiting
• Osteoporosis1 recruiting